# Lynparza

NDC: 0310-0569
Generic name: olaparib
Labeler / Manufacturer: AstraZeneca Pharmaceuticals LP
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20170817

FDA application: NDA208558

## Active ingredients

- OLAPARIB: 100 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0310-0569"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0310-0569
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=741ff3e3-dc1a-45a6-84e5-2481b27131aa